MRTX1133 RESISTANCE - AN OVERVIEW

The identification of KRASG12C inhibitors has reignited desire in targeting RAS proteins. This work describes the discovery of your KRASG12D-precise inhibitor MRTX1133 and demonstrates the feasibility of potently and selectively concentrating on this oncogenic variant.In addition, once the crew removed T cells from the mice, they identified that tu